This re-coverage is triggered by price dislocation rather than a new earnings release: the stock has fallen from about $28.04 in the 2026-09-04 DD to a verified $23.82 previous close, while Q2 fundamentals, August originations, insider buying and high short interest leave the thesis alive. The conclusion improves from merely moderate to favorable risk/reward, but it remains a credit-cycle trade with legal, funding and model-risk overhangs.
Company & Thesis AssessmentScore /100 - updated 2026-09-29
Base FV rises from $35 to $36 mostly because the credit-exposure reserve uses Q2 loans at fair value rather than broader exposure language, while the entry price has fallen materially. The implied revenue multiple is about 2.6x FY2026E revenue, inside the fintech/lender peer range. Cross-check using 12.5x FY2026E adjusted EBITDA of $294M less the same credit/legal reserves yields roughly $35-$37 per share. Sensitivity remains high: each 0.5x revenue multiple changes FV by about $7 per share. Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Unsecured lending platform | $1.15B FY2026E fee revenue x 2.55x equity/revenue multiple / 100.0M diluted shares | +29.33 |
| Secured products: auto and home | $105M FY2026E fee revenue x 3.5x option multiple / 100.0M diluted shares | +3.68 |
| Cash Line, HELOC and platform optionality | $45M FY2026E fee revenue x 4.5x option multiple / 100.0M diluted shares | +2.03 |
| Excess corporate liquidity | ($457.8M cash - $66.5M 2026 notes) / 100.0M diluted shares | +3.91 |
| Credit and fair-value exposure reserve | 10% reserve x $1.064B loans at fair value from Q2 2026 10-Q / 100.0M diluted shares | -1.06 |
| Litigation, ATM and dilution reserve | 5.0% haircut x $37.89 pre-reserve value for Model 22 class action, $500M ATM shelf and share-count creep | -1.89 |
| FV base case | 29.33 + 3.68 + 2.03 + 3.91 - 1.06 - 1.89 = $36.00 | $36.00 |
The short base is now large enough to matter in both directions. Clean monthly origination and Q3 earnings data could force covering, but any UMI deterioration or funding issue can validate the bearish side quickly.
| Item | FY2023 | FY2024 | FY2025 | TTM Jun26 | FY2026E |
|---|---|---|---|---|---|
| Revenue | $513.6M | $636.5M | $1.075B | ~$1.286B | ~$1.400B |
| Revenue from fees | N/D | N/D | ~$1.00B | N/D | ~$1.300B |
| Adjusted EBITDA | Negative | $10.6M | $230M | N/D | ~$294M |
| Loans at fair value | N/D | N/D | N/D | $1.064B | Monitor |
| Shares outstanding | N/D | ~86M | 98.0M | 97.3M | ~100M diluted model |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 257.3 | 285.9 | 280.3 | 308.2 | 364.7 |
| Contribution margin % | 58% | 60% | 57% | 56% | 55% |
| Net income ($M) | 5.6 | 31.8 | N/D | N/D | 16.5 |
| Cash EOP ($M) | N/D | N/D | 652.4 | 931.3 | 457.8 |
Business model - AI lending marketplace
Unsecured lending ~$1.15B FY2026E fees profitable core Q2 unsecured fee revenue was $326M, up 38% YoY, with 62% contribution margin. Secured: auto and home ~$105M FY2026E fees losses narrowing Contribution margin improved sharply but remains negative, making breakeven the next proof point. Cash Line and HELOC ~$45M FY2026E fees option value Newer credit products expand TAM but add regulatory and funding complexity. Capital partners 100+ banks/credit unions funding network Partner capital remains the main cycle variable and the decisive rerating input.
Legal, regulatory and risk analysis
SWOT analysis
- +Q2 growth and August originations still support FY2026 guidance.
- +Founder/CEO open-market buying improves the governance signal.
- +Lower price materially improves risk/reward versus the prior DD.
- −Short interest has increased and is now extremely high.
- −Loan fair-value exposure keeps the story tied to credit marks.
- −Secured products have not yet reached positive contribution margin.
- →September originations can prove whether August pace was durable.
- →A lower UMI reading would be a strong rerating catalyst.
- →Short covering can amplify a clean Q3 print.
- !Credit stress stays elevated into 2027.
- !Class-action discovery or ATM usage weighs on valuation.
- !Capital partners slow funding if cohort performance weakens.
Sources: Upstart Q2 2026 results release dated 2026-08-04; Upstart August 2026 originations and UMI release dated 2026-09-03; Upstart Q2 2026 Form 10-Q; StockAnalysis UPST statistics and forecast pages checked 2026-09-29; MarketBeat short-interest and forecast pages checked 2026-09-29; Yahoo Finance quote page checked 2026-09-29; Upstox US quote page checked 2026-09-29; Benzinga analyst-target page checked 2026-09-29; Bragar Eagel and Kirby McInerney class-action notices; Form4API / InsiderGlobe / FilingExplorer insider-purchase pages. Market data - last verified close 2026-09-28: UPST previous close $23.81-$23.82, market cap about $2.24B, enterprise value about $3.84B, shares outstanding 97.31M, 52W range roughly $22.80-$57.88, cash $457.8M and debt $2.06B. Short interest: 27.65M shares / 34.35% float as of 2026-09-15. This document is for informational purposes only and does not constitute financial or investment advice.